BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11049088)

  • 1. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
    Pettit GR; Lippert JW
    Anticancer Drug Des; 2000 Jun; 15(3):203-16. PubMed ID: 11049088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug.
    Pettit GR; Rhodes MR; Herald DL; Chaplin DJ; Stratford MR; Hamel E; Pettit RK; Chapuis JC; Oliva D
    Anticancer Drug Des; 1998 Dec; 13(8):981-93. PubMed ID: 10335271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugs.
    Pettit GR; Moser BR; Boyd MR; Schmidt JM; Pettit RK; Chapuis JC
    Anticancer Drug Des; 2001; 16(4-5):185-93. PubMed ID: 12049477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs.
    Pettit GR; Temple C; Narayanan VL; Varma R; Simpson MJ; Boyd MR; Rener GA; Bansal N
    Anticancer Drug Des; 1995 Jun; 10(4):299-309. PubMed ID: 7786396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineoplastic agents 389. New syntheses of the combretastatin A-4 prodrug.
    Pettit GR; Rhodes MR
    Anticancer Drug Des; 1998 Apr; 13(3):183-91. PubMed ID: 9595032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic agents. 379. Synthesis of phenstatin phosphate.
    Pettit GR; Toki B; Herald DL; Verdier-Pinard P; Boyd MR; Hamel E; Pettit RK
    J Med Chem; 1998 May; 41(10):1688-95. PubMed ID: 9572894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
    Pettit GR; Thornhill A; Melody N; Knight JC
    J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
    Pettit GR; Minardi MD; Rosenberg HJ; Hamel E; Bibby MC; Martin SW; Jung MK; Pettit RK; Cuthbertson TJ; Chapuis JC
    J Nat Prod; 2005 Oct; 68(10):1450-8. PubMed ID: 16252907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineoplastic agents 463. Synthesis of combretastatin A-3 diphosphate prodrugs.
    Pettit GR; Minardi MD; Boyd MR; Pettit RK
    Anticancer Drug Des; 2000 Dec; 15(6):397-403. PubMed ID: 11716432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic agents 442. Synthesis and biological activities of dioxostatin.
    Pettit GR; Lippert JW; Boyd MR; Verdier-Pinard P; Hamel E
    Anticancer Drug Des; 2000 Oct; 15(5):361-71. PubMed ID: 11354312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic agents 453. Synthesis of pancratistatin prodrugs.
    Pettit GR; Orr B; Ducki S
    Anticancer Drug Des; 2000 Dec; 15(6):389-95. PubMed ID: 11716431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug.
    Grosios K; Holwell SE; McGown AT; Pettit GR; Bibby MC
    Br J Cancer; 1999 Dec; 81(8):1318-27. PubMed ID: 10604728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate.
    Holwell SE; Cooper PA; Thompson MJ; Pettit GR; Lippert LW; Martin SW; Bibby MC
    Anticancer Res; 2002; 22(6C):3933-40. PubMed ID: 12553015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
    Kaffy J; Pontikis R; Florent JC; Monneret C
    Org Biomol Chem; 2005 Jul; 3(14):2657-60. PubMed ID: 15999202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic agents 500. Narcistatin.
    Pettit GR; Melody N; Simpson M; Thompson M; Herald DL; Knight JC
    J Nat Prod; 2003 Jan; 66(1):92-6. PubMed ID: 12542352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combretastatin A-1 phosphate a novel tubulin-binding agent with in vivo anti vascular effects in experimental tumours.
    Holwell SE; Cooper PA; Grosios K; Lippert JW; Pettit GR; Shnyder SD; Bibby MC
    Anticancer Res; 2002; 22(2A):707-11. PubMed ID: 12017147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate.
    Edsall AB; Agoston GE; Treston AM; Plum SM; McClanahan RH; Lu TS; Song W; Cushman M
    J Med Chem; 2007 Dec; 50(26):6700-5. PubMed ID: 18052315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents.
    Wu M; Sun Q; Yang C; Chen D; Ding J; Chen Y; Lin L; Xie Y
    Bioorg Med Chem Lett; 2007 Feb; 17(4):869-73. PubMed ID: 17174089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic agents 320: synthesis of a practical pancratistatin prodrug.
    Pettit GR; Freeman S; Simpson MJ; Thompson MA; Boyd MR; Williams MD; Pettit GR; Doubek DL
    Anticancer Drug Des; 1995 Apr; 10(3):243-50. PubMed ID: 7748458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
    J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.